Annexus Health, Inc., a Sewickley, PA-based healthcare technology company, raised USD33m in Series B financing.
The round was led by Transformation Capital.
The company intends to use the funds to expand operations and its development efforts.
Led by President Brad Frazier, and CEO Joe Baffone, Annexus Health provides solutions that reduce the administrative burden on physicians and health systems by streamlining the management of access services, including financial assistance, benefit eligibility, patient cost estimates, free drug, reimbursement services, and more. The company also offers life science companies and charitable foundations the opportunity to digitally integrate their patient support programs directly within the provider workflow.
Annexus Health’s provider solutions, AssistPoint® and Adparo®, help provider organizations navigate the patient access journey, while reducing administrative burden for providers. Recently, the company has grown its provider network to nearly 20% of the community oncology market, which includes New York Cancer and Blood Specialists and a recently announced partnership with American Oncology Network, LLC (AON). Annexus Health helps these groups make financial assistance programs available to more patients and has surpassed $2 billion in financial assistance awards processed. Building on the value proposition its solutions offer to oncologists and their patients, Annexus Health is rapidly expanding into other disease states, including ophthalmology, urology, and rheumatoid arthritis, which will service many additional physicians.
The company’s AP Connect™ solution offers life science companies and charitable organizations the ability to digitally integrate their patient support programs directly within the provider workflow. Annexus Health has a wide range of life science partnerships to date, including Amgen and BeiGene.
FinSMEs
02/08/2022